Publications

5808 Results

Value of information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics

Authors
JJ Carlson;R Thariani;J Roth;J Gralow;NL Henry;L Esmail;P Deverka;S Ramsey;L Baker;D Veenstra
Journal / Conference
Medical Decision Making, 33(4):463-471;
Year
2013
Research Committee(s)
Breast
PMID
PMID2365833
PMC
PMC3933300
Study Number(s)
S1007

A randomized, double blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in persons with resected stage I non-small cell lung cancer (ECOG 5597)

Authors
D Karp;S Lee;S Keller;G Shaw Wright;S Aisner;S Belinsky;D Johnson;M Johnston;G Goodman;G Clamon;G Okawara;R Marks;E Frechette;W McCaskill-Stevens;SM Lippman;J Ruckdeschel;F Khuri
Journal / Conference
Journal of Clinical Oncology 31(33):4179-4187;
Year
2013
Research Committee(s)
Lung
PMID
PMID24002495
PMC
PMC3821010
Study Number(s)
E5597

Relevance of platinum (plat) sensitivity status in previously treated extensive stage small cell lung cancer (ES-SCLC) in the modern era: a patient level analysis of SWOG trials

Authors
P Lara, Jr;J Moon;M Redman;K Kelly;J Allen;B Gitlitz;PC Mack;D Gandara
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr 7511); ASCO Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
Year
2013
Research Committee(s)
Lung
Study Number(s)
S0327, S0435, S0802

A phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor-(HR) positive and Her2-neu-negative breast cancer: SWOG-NSABP S1207

Authors
M Chavez-Macgregor;W Barlow;AM Gonzalez-Angulo;P Rastogi;E Mamounas;P Ganz;AF Schott;S Paik;D Lew;H Bandos;G Hortobagyi
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr TPS657); 2013. American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), TIPS general poster session;
Year
2013
Research Committee(s)
Breast
PMID
https://meetinglibrary.asco.org/record/86424/abstract
Study Number(s)
S1207

Markers of angiogenesis and hypoxia in germinal center B cell (GCB) and non-GCB subtypes of diffuse large B cell non-hodgkin lymphoma (DLBCL): correlative studies from S0515, a phase II trial of R-CHOP plus bevacizumab

Authors
B Ambuga;M Abu Zaid;J Unger;L Rimsza;M Marron;RI Fisher;TP Miller;A Stopeck
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr 8562); ASCO Annual Meeting (May 31-June 4, 2013, Chicago, IL), general poster discussion;
Year
2013
Research Committee(s)
Lymphoma
Study Number(s)
S0515

The effect of renal function on outcomes in the adjuvant treatment of older women with breast cancer. An ancillary data study of CALGB/CTSU 49907 (for the Alliance for Clinical Trials in Oncology

Authors
SM Lichtman;C Cirrincione;A Hurria;A Jatoi;J Gralow;HJ Cohen;H Muss
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr 9515); American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
Year
2013
Research Committee(s)
Breast

A phase I study of cediranib (NSC #732208) in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma (SWOG S0905)

Authors
A Tsao;J Moon;I Wistuba;N Vogelzang;G Kalemkerian;M Redman;D Gandara
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr 7527); American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
Year
2013
Research Committee(s)
Lung
Study Number(s)
S0905

SWOG S1115: randomized phase II clinical trial of AZD6244 hydrogen sulfate (NSC-748727) and MK-2206 (NSC-749607) vs mFOLFOX in patients with metastatic pancreatic cancer after prior chemotherapy

Authors
V Chung;S McDonough;P Philip;D Backlund Cardin;A Lowy;J Benedetti;CD Blanke
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr TPS4145); American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), TIPS general poster;
Year
2013
Research Committee(s)
Gastrointestinal
Study Number(s)
S1115

Elderly IPI (EIPI) in DLBCL pts age >60 treated with RCHOP: international validation study using data from RICOVER-60 (German High Grade Non-Hodgkin Lymphoma Study Group) and LNH 98-5 (Groupe D'Etude de Lymphome d'Adultes)

Authors
R Advani;F Hong;TM Habermann;BS Kahl;VA Morrison;EA Weller;G Varma;RI Fisher;BA Peterson;B Cheson;RD Gascoyne;SJ Horning;S Bousetta;B Coiffier;M Ziepert;M Pfreudschuh
Journal / Conference
Hematological Oncology 31(suppl.1):abstr.#222, p.171; Int'l. Conference on Malignant Lymphoma (June 19-22, 2013, Lugano, Switzerland), poster presentation;
Year
2013
Research Committee(s)
Lymphoma
Study Number(s)
E4494

Patterns of failure (POF) in a randomized phase III trial of ABVD vs. Stanford V +/- radiation therapy in locally extensive and advanced stage hodgkin's lymphoma (HL): an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

Authors
H Wagner;LI Gordon;F Hong;TJ Fitzgerald;F Laurie;RI Fisher;N Bartlett;J Connors;R Gascoyne;P Stiff;B Cheson;M Gospodarowicz;R Advani;B Kahl;J Friedberg;K Blum;T Habermann;J Tuscano;R Hoppe;SJ Horning
Journal / Conference
Hematological Oncology 31(suppl.1):abstr. #256, p.182; Int'l Conference on Malignant Lymphoma (June 19-22, 2013, Lugano, Switzerland), poster presentation;
Year
2013
Research Committee(s)
Lymphoma
Study Number(s)
E2496